UNMATCHED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

626
Active Clinical Trials
9
Commercial Products
550,000+
Shipments
150+
Countries
Takeda-BioLife-Box 
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

Upcoming Events View All

OCT2

World Dairy Expo 2022

Date: October 2-7, 2022
Location: Madison, WI

OCT6

Advances in Advanced Therapy Manufacture 2022

Date: October 6, 2022
Location: Amsterdam, The Netherlands

The Latest From Our Blog View All

The Cryoport Way: A Leap Forward in Standardizing the Regenerative Medicine Supply Chain

As cell and gene therapies are rapidly moving beyond clinical trials and into commercial markets, the safe and effective delivery of these life-saving treatments needs to be a priority for advanced therapy developers. Can the same supply chain solutions, processes, and systems used during the clinical trial phases handle the increased volume of a commercial therapy on a global basis? The significant growth and rapid innovation of the regenerative medicine industry increases the complexities and risks associated with transporting therapies when shipping in a non-compliant environment. This places unique pressure on supply chain providers to standardize their processes and become far more agile, all while maintaining operational excellence in a zero-failure environment.  

Cryoport Systems’ Global BioServices: Secondary Packaging and Labeling Solutions

Cryoport Systems’ highly anticipated Global Supply Chain Centers have been operational for a few months, and customers continue to move biopharmaceutical materials into our Houston, Texas and Morris Plains, New Jersey facilities in order to mitigate risks.

Our new Global Supply Chain Centers were established in direct response to client requests, and represent the initial stages of a global network that offers specialized logistics support and BioServices solutions. Therapy developers require dependable partners with suitable facilities to help them manage their valuable materials, such as therapeutic products and manufacturing raw materials.

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Cryoport Systems has officially launched our BioServices solutions through our two new Global Supply Chain Centers. Learn More